| AstraZeneca AG - Faslodex, Injektionslösung |
| 56778 | | 01 | | Faslodex | | Injektionslösung | | L02BA03 | | Fulvestrant | | 19.03.2004 | | |
|
| Composition |
| fulvestrantum 250 mg, ethanolum 96 per centum 500 mg, alcohol benzylicus 500 mg, benzylis benzoas 750 mg, ricini oleum virginale q.s. ad solutionem pro 5 ml corresp., ethanolum 12 % V/V. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Fulvestrant | 250mg / 5ml |
| | BAG: Active Agent | Dose |
|---|
| Fulvestrant | 250 mg |
| | | | Inactive agents | Dose |
|---|
| Alcohol Benzylicus | 500mg / 5ml | | Benzyl Benzoate | 750mg / 5ml | | Ethanolum 96 Per Centum | 500mg / 5ml | | Ricini Oleum Virginale | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 012 | 2 syringe(s) | 329.81 | 379.80 | B | SL | Yes |
|
